OptimizeRx (OPRX) News Today $10.70 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 27 at 1:40 AM | americanbankingnews.comOptimizeRx Co. (NASDAQ:OPRX) Forecasted to Earn Q2 2024 Earnings of ($0.26) Per ShareJuly 26 at 8:00 AM | marketbeat.comEquities Analysts Issue Forecasts for OptimizeRx Co.'s Q2 2024 Earnings (NASDAQ:OPRX)OptimizeRx Co. (NASDAQ:OPRX - Free Report) - B. Riley issued their Q2 2024 earnings estimates for shares of OptimizeRx in a research report issued on Wednesday, July 24th. B. Riley analyst K. Bauser expects that the company will earn ($0.26) per share for the quarter. B. Riley has a "Buy" ratingJuly 26 at 7:34 AM | americanbankingnews.comOptimizeRx (NASDAQ:OPRX) Coverage Initiated by Analysts at B. RileyJuly 25 at 9:16 AM | marketbeat.comOptimizeRx (NASDAQ:OPRX) Research Coverage Started at B. RileyB. Riley started coverage on OptimizeRx in a research note on Thursday. They issued a "buy" rating and a $18.50 price objective on the stock.July 25 at 7:30 AM | globenewswire.comOptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ETJuly 23, 2024 | globenewswire.comOptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy LegislationJuly 21, 2024 | americanbankingnews.comOptimizeRx Co. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by AnalystsJuly 21, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of OptimizeRx Co. (NASDAQ:OPRX - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the coJuly 15, 2024 | globenewswire.comOptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach PatientsJuly 11, 2024 | marketbeat.comEssex Investment Management Co. LLC Purchases New Stake in OptimizeRx Co. (NASDAQ:OPRX)Essex Investment Management Co. LLC bought a new stake in OptimizeRx Co. (NASDAQ:OPRX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm bought 86,656 shares of the company's stock, valued at approximately $1,053,000. Essex Investment ManagemeJune 21, 2024 | marketbeat.comJMP Securities Reiterates Market Outperform Rating for OptimizeRx (NASDAQ:OPRX)JMP Securities reaffirmed a "market outperform" rating and issued a $16.00 price objective on shares of OptimizeRx in a research note on Friday.June 20, 2024 | globenewswire.comNew White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical ConversationsJune 13, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by G2 Investment Partners Management LLCG2 Investment Partners Management LLC boosted its position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 26.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 468,120 shares of the company's stock after purchasing an additional 96,646 shareJune 12, 2024 | marketbeat.comFirst Light Asset Management LLC Lowers Holdings in OptimizeRx Co. (NASDAQ:OPRX)First Light Asset Management LLC decreased its position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 30.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,727,298 shares of the company's stock after selling 758,749 shares during the period. OptJune 11, 2024 | marketbeat.comAvenir Corp Has $1.26 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX)Avenir Corp trimmed its position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 71.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,260 shares of the company's stock after sJune 1, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of OptimizeRx Co. (NASDAQ:OPRX - Get Free Report) have earned an average rating of "Moderate Buy" from the seven brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12-May 27, 2024 | marketbeat.comMillrace Asset Group Inc. Purchases Shares of 133,936 OptimizeRx Co. (NASDAQ:OPRX)Millrace Asset Group Inc. purchased a new stake in OptimizeRx Co. (NASDAQ:OPRX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 133,936 shares of the company's stock, valued aMay 15, 2024 | finanznachrichten.deOptimizeRx Corporation: OptimizeRx Reports First Quarter 2024 Financial ResultsMay 15, 2024 | marketwatch.comOptimizeRx Shares Rise 23% on 1Q Revenue Beat, FY GuidanceMay 15, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)May 15, 2024 | msn.comOptimizeRx Corporation (NASDAQ:OPRX) Q1 2024 Earnings Call TranscriptMay 15, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) PT Raised to $16.00 at JMP SecuritiesJMP Securities boosted their price target on OptimizeRx from $15.00 to $16.00 and gave the company a "market outperform" rating in a research report on Wednesday.May 15, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Issues Quarterly Earnings Results, Misses Estimates By $0.16 EPSOptimizeRx (NASDAQ:OPRX - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.16). The firm had revenue of $19.69 million during the quarter, compared to analysts' expectations of $18.66 million. OptimizeRx had a negative return on equity of 7.72% and a negative net margin of 24.56%. During the same period last year, the firm posted ($0.34) earnings per share.May 15, 2024 | marketbeat.comStifel Nicolaus Reiterates Buy Rating for OptimizeRx (NASDAQ:OPRX)Stifel Nicolaus reiterated a "buy" rating and set a $13.00 price objective on shares of OptimizeRx in a report on Wednesday.May 15, 2024 | finance.yahoo.comOptimizeRx Corp (OPRX) Q1 2024 Earnings Call Transcript Highlights: Surging Revenues and ...May 14, 2024 | investorplace.comOPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | globenewswire.comOptimizeRx Reports First Quarter 2024 Financial ResultsMay 7, 2024 | marketbeat.comOptimizeRx (OPRX) Set to Announce Earnings on TuesdayOptimizeRx (NASDAQ:OPRX) will be releasing earnings after the market closes on Tuesday, May 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=590375)May 6, 2024 | globenewswire.comOptimizeRx to Participate in Upcoming Investor ConferencesApril 29, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for AbbVie: Future Growth Beyond Humira’s CompetitionApril 28, 2024 | marketbeat.comFederated Hermes Inc. Has $2.62 Million Holdings in OptimizeRx Co. (NASDAQ:OPRX)Federated Hermes Inc. lowered its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 47.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 182,985 shares of the company's stock after selling 1April 26, 2024 | globenewswire.comOptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ETApril 18, 2024 | globenewswire.comOptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) ReportApril 16, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Earns "Market Outperform" Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $15.00 price target on shares of OptimizeRx in a report on Tuesday.April 16, 2024 | globenewswire.comOptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsApril 13, 2024 | stockhouse.comOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | finance.yahoo.comOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | finance.yahoo.comOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | globenewswire.comOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a RowApril 6, 2024 | investorplace.com7 Top Undervalued Stocks Primed for a Multibagger RecoveryApril 4, 2024 | markets.businessinsider.comOptimizeRx: A Strong Buy on Strategic Acquisitions and Innovative Platform ExpansionApril 4, 2024 | marketbeat.comJMP Securities Begins Coverage on OptimizeRx (NASDAQ:OPRX)JMP Securities started coverage on shares of OptimizeRx in a report on Thursday. They issued an "outperform" rating and a $15.00 price objective on the stock.April 2, 2024 | au.lifestyle.yahoo.comTesla blames sales drop on Houthi attacks and arson in GermanyApril 1, 2024 | msn.comAriana Madix To Host ‘Love Island USA’ as Sarah Hyland Departs FranchiseApril 1, 2024 | au.news.yahoo.comCanoo spent double its annual revenue on the CEO’s private jet in 2023April 1, 2024 | finance.yahoo.comOptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call TranscriptApril 1, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Stock Rating Reaffirmed by Stifel NicolausStifel Nicolaus reissued a "buy" rating and set a $13.00 price target on shares of OptimizeRx in a report on Monday.March 29, 2024 | finance.yahoo.comQ4 2023 OPTIMIZERx Corp Earnings CallMarch 28, 2024 | investorplace.comOPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023March 28, 2024 | msn.comOptimizeRx Q4 revenue $28.4M Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here OPRX Media Mentions By Week OPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPRX News Sentiment▼0.640.53▲Average Computer and Technology News Sentiment OPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPRX Articles This Week▼122▲OPRX Articles Average Week Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Resources Connection News Liquidity Services News Xometry News Yext News International Money Express News OmniAb News Gravity News Absci News MaxCyte News Sohu.com News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPRX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
